Research Article

Impact of a multidisciplinary pre-dialysis program on renal treatment modalities choice

Luis Miguel Castro Fonseca dos Santos Oliveira*, Rui Arlindo dos Santos Alves de Castro and Teresa Margarida Ribeiro Pinto Morgado

Published: 05/05/2021 | Volume 5 - Issue 2 | Pages: 047-052

In Portugal, around 2500 patients with end-stage chronic kidney disease (CKD stage 5) start a renal replacement therapy (RRT) for the first time each year [1]. They have four main treatment options: kidney transplantation (TX); haemodialysis (HD); peritoneal dialysis (PD) and conservative treatment (CT). RRT selection is quite complex due to the specificities of each option and to their profound effect on patient’s quality of life. Patients must play a decisive role in the choice of treatment modality and select the option that best suits to their values and needs.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001073 Cite this Article

References

  1. Galvão A, Filipe R, Carvalho M. Relatório Gabinete de Registo da SPN. Portuguese registry of dialysis and transplantation 2017 - Encontro renal março de 2018. Vilamoura: SPN. 2018.
  2. Gulland A. Welcome to the century of the patient. BMJ. 2011; 342: d2057. PubMed: https://pubmed.ncbi.nlm.nih.gov/21471162/
  3. O’Connor A, Stacey D, Lewis K, Barry MJ, Bennett CL, et al. Decision aids for people facing health treatment or screening decisions (Review). Cochrane Database Sys Rev. 2009; 3: CD001431. PubMed: https://pubmed.ncbi.nlm.nih.gov/28402085/
  4. Smart N, Titus T. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med. 2011; 124: 1073–1080. PubMed: https://pubmed.ncbi.nlm.nih.gov/22017785/
  5. Chiang P, Jia-Jeng H, Ing-Ching J, Peir-Haur H3, Chih-Yen H, et al. Factors Associated with the Choice of Peritoneal Dialysis in Patients with End-Stage Renal Disease. BioMed Res Int. 2016; 2016: 5314719.
  6. Kutner N, Zhang R, Huang Y, Wasse H. Patient awareness and initiation of peritoneal dialysis. Arch Intern Med. 2011; 171: 119–124. PubMed: https://pubmed.ncbi.nlm.nih.gov/20876396/
  7. DGS - Tratamento Conservador Médico da Insuficiência Renal Crónica Estádio 5. Norma nº 017/2011. 2011.
  8. Goovaerts T, Jadoul M, Goffin E. Influence of a Pre Dialysis Education Programme (PDEP) on the mode of renal replacementtherapy, Nephrology Dialysis Transplantation. 2005; 20: 1842–1847. PubMed: https://pubmed.ncbi.nlm.nih.gov/15919693/
  9. Little J, Irwin A, Marshall T, Rayner H, Smith S. Predicting a patient’s choice of dialysis modality: experience in a United Kingdom renal department. Am J Kidney Dis. 2001; 37: 981–986. PubMed: https://pubmed.ncbi.nlm.nih.gov/11325680/
  10. Dimitrios C, Khai N, Bassam F, Baharani J. What influences patient choice of treatment modality at the pre dialysis stage? Nephrol Dial Transplant. 2012; 27: 1542–1547. PubMed: https://pubmed.ncbi.nlm.nih.gov/21865216/  
  11. Palmer S, Berardis G, Craig JC, Tong A, Tonelli  M, et al. Patient satisfaction with in-centre haemodialysis care: an international survey. BMJ Open. 2014; 4: e005020. PubMed: https://pubmed.ncbi.nlm.nih.gov/24840250/
  12. Golper T. Patient education: can it maximize the success of therapy? Nephrol Dial Transplant. 2001; 16: 20-24. PubMed: https://pubmed.ncbi.nlm.nih.gov/11590252/  
  13. Tejedor A, Sanz F, Perez N. Atención domiciliaria al paciente urémico terminal no susceptible de diálisis. Nefrología. 2006; 26: 66–81.
  14. Morton RL, Turner RM, Howard K, Snelling P, Webster AC. Patients who plan for conservative care rather than dialysis: a National Observational Study in Australia. Am J Kidney Dis. 2012; 59: 419–427. PubMed: https://pubmed.ncbi.nlm.nih.gov/22014401/
  15. Teruel J, Vion V, Couto A, Gorrín MR, Fernández-Lucas M, et al. Choosing conservative therapy in chronic kidney disease. Nefrologia. 2015; 35: 273-279. PubMed: https://pubmed.ncbi.nlm.nih.gov/26299170/